{"id":1254,"date":"2025-10-16T09:12:12","date_gmt":"2025-10-16T09:12:12","guid":{"rendered":"https:\/\/www.onusrobotichospitals.com\/curox\/?page_id=1254"},"modified":"2025-10-31T14:14:40","modified_gmt":"2025-10-31T14:14:40","slug":"stem-cell-therapy-in-orthopedics","status":"publish","type":"page","link":"https:\/\/www.onusrobotichospitals.com\/regenerative\/curox\/stem-cell-therapy-in-orthopedics\/","title":{"rendered":"Stem Cell Therapy In Orthopedics"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"1254\" class=\"elementor elementor-1254\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a791bf9 e-con-full e-flex e-con e-parent\" data-id=\"a791bf9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9e2da1b elementor-widget elementor-widget-image\" data-id=\"9e2da1b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"250\" src=\"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-content\/uploads\/2025\/10\/Advanced-Regeneration-Through-Stem-Cells-1024x320.jpg\" class=\"attachment-large size-large wp-image-1706\" alt=\"\" srcset=\"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-content\/uploads\/2025\/10\/Advanced-Regeneration-Through-Stem-Cells-1024x320.jpg 1024w, https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-content\/uploads\/2025\/10\/Advanced-Regeneration-Through-Stem-Cells-300x94.jpg 300w, https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-content\/uploads\/2025\/10\/Advanced-Regeneration-Through-Stem-Cells-768x240.jpg 768w, https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-content\/uploads\/2025\/10\/Advanced-Regeneration-Through-Stem-Cells-1536x480.jpg 1536w, https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-content\/uploads\/2025\/10\/Advanced-Regeneration-Through-Stem-Cells.jpg 1920w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7f517a8 e-flex e-con-boxed e-con e-parent\" data-id=\"7f517a8\" data-element_type=\"container\" data-e-type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3368f58 elementor-widget elementor-widget-heading\" data-id=\"3368f58\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">What \u201cstem cell therapy\u201d means in orthopedics (short)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3916ce1 elementor-widget elementor-widget-text-editor\" data-id=\"3916ce1\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><span style=\"font-weight: 400;\">Most orthopaedic \u201cstem-cell\u201d treatments use <\/span><b>mesenchymal stromal\/stem cells (MSCs)<\/b><span style=\"font-weight: 400;\"> or concentrated bone-marrow\/adipose cell fractions. In practice these treatments are usually delivered as:<\/span><\/p><ul><li style=\"font-weight: 400;\" aria-level=\"1\"><b>Bone marrow aspirate concentrate (BMAC)<\/b><span style=\"font-weight: 400;\"> (point-of-care concentrate from iliac crest),<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><b>Adipose-derived stromal vascular fraction (SVF) or micro-fragmented adipose tissue<\/b><span style=\"font-weight: 400;\">,<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><b>Culture-expanded MSCs<\/b><span style=\"font-weight: 400;\"> (cells grown in a lab to increase numbers), or<\/span><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><b>Allogeneic &#8220;off-the-shelf&#8221; MSC products<\/b><span style=\"font-weight: 400;\"> (donor-derived).<\/span><span style=\"font-weight: 400;\"><br \/><\/span><span style=\"font-weight: 400;\">Mechanistically MSCs act largely by <\/span><b>paracrine and immunomodulatory effects<\/b><span style=\"font-weight: 400;\"> (growth factors, cytokines) that reduce inflammation and stimulate local repair rather than by permanently becoming new cartilage or tendon in large numbers<\/span><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-2a6f486 elementor-widget elementor-widget-heading\" data-id=\"2a6f486\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">How they\u2019re thought to help (mechanisms)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-561bdad elementor-widget elementor-widget-text-editor\" data-id=\"561bdad\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li style=\"font-weight: 400;\" aria-level=\"1\"><b>Anti-inflammatory \/ immunomodulation:<\/b><span style=\"font-weight: 400;\"> MSCs lower local inflammation which can reduce pain and slow degeneration. <\/span><a href=\"https:\/\/www.nature.com\/articles\/s41392-023-01670-7?utm_source=chatgpt.com\"><span style=\"font-weight: 400;\">Nature<\/span><\/a><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><b>Paracrine trophic effects:<\/b><span style=\"font-weight: 400;\"> MSCs secrete growth factors that recruit local cells, promote angiogenesis and matrix production. <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10105961\/?utm_source=chatgpt.com\"><span style=\"font-weight: 400;\">PMC<\/span><\/a><\/li><li style=\"font-weight: 400;\" aria-level=\"1\"><b>Differentiation (limited):<\/b><span style=\"font-weight: 400;\"> In some settings MSCs can differentiate toward bone\/cartilage\/tendon cells, but long-term engraftment is uncommon \u2014 most benefit appears driven by secreted factors.\u00a0<\/span><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0099f43 elementor-widget elementor-widget-heading\" data-id=\"0099f43\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Realistic indications in orthopedics \u2014 what the literature actually shows<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c711c35 elementor-widget elementor-widget-text-editor\" data-id=\"c711c35\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p><b>Important bottom-line:<\/b><span style=\"font-weight: 400;\"> No mainstream orthopaedic condition is universally \u201ccured\u201d by stem cells. Evidence ranges from promising (symptom relief, structural signals) to mixed or insufficient. Use of stem cells should be discussed as <\/span><b>evidence-based but often investigational<\/b><span style=\"font-weight: 400;\"> for many indications.<\/span><\/p><p><span style=\"font-weight: 400;\">Below are common orthopaedic indications with a plain-language summary + the evidence level.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b1a40f6 elementor-widget elementor-widget-heading\" data-id=\"b1a40f6\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">1. Knee osteoarthritis (OA)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-6d97504 elementor-widget elementor-widget-text-editor\" data-id=\"6d97504\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li aria-level=\"1\"><b>What clinicians see:<\/b>\u00a0Multiple randomized trials and meta-analyses report\u00a0<b>short-to-mid-term improvements in pain and function<\/b>\u00a0after intra-articular MSC or BMAC injections (weeks\u201312 months). However study methods vary widely and long-term structural cartilage regeneration remains\u00a0<b>uncertain<\/b>. Systematic reviews (including recent Cochrane \/ meta-analyses) conclude results are promising but heterogeneous and more high-quality trials are needed.\u00a0<b>Best candidates<\/b>\u00a0tend to be younger patients with early\u2013moderate OA (KL II\u2013III), not end-stage OA.\u00a0<a href=\"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD013342.pub2\/related-content?utm_source=chatgpt.com\">cochranelibrary.com+2PMC+2<\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ae5983d elementor-widget elementor-widget-heading\" data-id=\"ae5983d\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">2. Focal cartilage defects &amp; cartilage repair (e.g., post-traumatic chondral lesions)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b11bdc8 elementor-widget elementor-widget-text-editor\" data-id=\"b11bdc8\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li><b>Evidence:<\/b><span style=\"font-weight: 400;\"> Clinical series and small trials (including culture-expanded MSCs combined with scaffolds or microfracture) show improved symptoms and some MRI\/arthroscopic evidence of repair. These are promising for focal defects (as an adjunct to microfracture\/ACI techniques) but results vary by technique and lesion size. Longer follow-up and comparative RCTs remain limited. <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5822962\/?utm_source=chatgpt.com\"><span style=\"font-weight: 400;\">PMC+1<\/span><\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bab2c9a elementor-widget elementor-widget-heading\" data-id=\"bab2c9a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">3. Meniscal injuries (after partial meniscectomy \/ meniscal repair)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-3fdfff9 elementor-widget elementor-widget-text-editor\" data-id=\"3fdfff9\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li><b>Evidence:<\/b><span style=\"font-weight: 400;\"> Small randomized and pilot studies (e.g., Vangsness et al.) reported increased meniscal volume on MRI and improved pain in some patients after intra-articular MSC injections. This suggests potential to improve meniscal healing in select cases \u2014 still early evidence. <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24430407\/?utm_source=chatgpt.com\"><span style=\"font-weight: 400;\">PubMed+1<\/span><\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-e533abe elementor-widget elementor-widget-heading\" data-id=\"e533abe\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">4. Rotator cuff and tendon injuries<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-31cd798 elementor-widget elementor-widget-text-editor\" data-id=\"31cd798\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li><b>Evidence:<\/b><span style=\"font-weight: 400;\"> Preclinical and clinical studies indicate MSC augmentation (injection or biologic augmentation at repair) can <\/span><b>reduce re-tear rates and improve healing quality<\/b><span style=\"font-weight: 400;\"> in some series; randomized data are still limited but growing. These are promising as an adjunct to surgical repair, not as a guaranteed standalone cure. <\/span><a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10970404\/?utm_source=chatgpt.com\"><span style=\"font-weight: 400;\">PMC+1<\/span><\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-dfd1717 elementor-widget elementor-widget-heading\" data-id=\"dfd1717\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">5. Avascular necrosis (osteonecrosis) of femoral head (early stage)<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0dbe0ea elementor-widget elementor-widget-text-editor\" data-id=\"0dbe0ea\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li><b>Evidence:<\/b><span style=\"font-weight: 400;\"> Combining core decompression with implantation of bone-marrow derived cells (BMMNC\/BMAC\/MSCs) has shown <\/span><b>reduced progression<\/b><span style=\"font-weight: 400;\"> to collapse and lower conversion to arthroplasty in several meta-analyses for early\/pre-collapse disease. Best outcomes are in <\/span><b>early (pre-collapse)<\/b><span style=\"font-weight: 400;\"> stages. <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37533122\/?utm_source=chatgpt.com\"><span style=\"font-weight: 400;\">PubMed+1<\/span><\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-214c2fc elementor-widget elementor-widget-heading\" data-id=\"214c2fc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">6. Fracture non-union \/ delayed union &amp; bone defects<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-bd45899 elementor-widget elementor-widget-text-editor\" data-id=\"bd45899\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li><b>Evidence:<\/b><span style=\"font-weight: 400;\"> Clinical pilot studies and small trials show <\/span><b>improved bone healing rates<\/b><span style=\"font-weight: 400;\"> for some non-unions when cell therapy (autologous or allogeneic bone-forming cells) is used percutaneously or with scaffolds \u2014 data are promising but heterogeneous and not uniformly superior to standard grafting in all series. <\/span><a href=\"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02432-4?utm_source=chatgpt.com\"><span style=\"font-weight: 400;\">BioMed Central+1<\/span><\/a><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-35f78c4 elementor-widget elementor-widget-heading\" data-id=\"35f78c4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">7. Ligament (ACL) augmentation and graft healing<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-563189e elementor-widget elementor-widget-text-editor\" data-id=\"563189e\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li><b>Evidence:<\/b><span style=\"font-weight: 400;\"> Preclinical data are strong; human trials show <\/span><b>safety<\/b><span style=\"font-weight: 400;\"> and some biological signals of improved graft maturation, but consistent clinical superiority (reduced laxity or better functional outcomes) has not been definitively proven yet. Most use is still investigational\/adjunctive.<\/span><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>What \u201cstem cell therapy\u201d means in orthopedics (short) Most orthopaedic \u201cstem-cell\u201d treatments use mesenchymal stromal\/stem cells (MSCs) or concentrated bone-marrow\/adipose cell fractions. In practice these treatments are usually delivered as: Bone marrow aspirate concentrate (BMAC) (point-of-care concentrate from iliac crest), Adipose-derived stromal vascular fraction (SVF) or micro-fragmented adipose tissue, Culture-expanded MSCs (cells grown in a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1473,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1254","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-json\/wp\/v2\/pages\/1254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-json\/wp\/v2\/comments?post=1254"}],"version-history":[{"count":79,"href":"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-json\/wp\/v2\/pages\/1254\/revisions"}],"predecessor-version":[{"id":2492,"href":"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-json\/wp\/v2\/pages\/1254\/revisions\/2492"}],"up":[{"embeddable":true,"href":"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-json\/wp\/v2\/pages\/1473"}],"wp:attachment":[{"href":"https:\/\/www.onusrobotichospitals.com\/regenerative\/wp-json\/wp\/v2\/media?parent=1254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}